Under construction – not a live service
Sign in
Enrolling by invitationNo phase

Localized Analysis of Normalized Distance From Scalp to Cortex and Personalized Evaluation (LANDSCAPE)

Key facts

Where
Hong Kong, Hong KongSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 60 and 95 years old?

Source: NCT05967390, who can take part

Where in Hong Kong

  • Tai Po HospitalHong Kong, Hong KongNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Chinese University of Hong Kong
Trial code
NCT05967390
Record updated
14 January 2025
Original description
Scalp to cortex distance (SCD), as a key technological parameter of brain stimulation, has been highlighted in the guidelines of non-invasive brain stimulation. However, in the context of age-related brain changes, the region-specific SCD and its impact on stimulation-induced electric field in different types of neurodegenerative diseases remain unclear.Read full original descriptionShow less

Localized Analysis of Normalized Distance From Scalp to Cortex and Personalized Evaluation (LANDSCAPE): A Project of MRI-informed Computational Head Model

Scalp to cortex distance (SCD), as a key technological parameter of brain stimulation, has been highlighted in the guidelines of non-invasive brain stimulation. However, in the context of age-related brain changes, the region-specific SCD and its impact on stimulation-induced electric field in different types of neurodegenerative diseases remain unclear.

Inclusion: Right-handed as assessed by the Edinburgh Inventory; Able to attend TMS interventions; Consent; Independent in daily life activities.

Exclusion: Evolutive disease (such as cancer); Neurological or psychiatric antecedent; Uncorrected visual or auditive deficits not allowing the realization of the test; Counter-indication to MRI.

ClinicalTrials.gov NCT05967390